Recursion Pharmaceuticals has been trying to rebuild momentum after a steep five year decline in shareholder returns, yet its ...

Short interest data from late June 2026 highlights deeply divided investor sentiment across the healthcare sector. Strong bearish bets remain heavily concentrated in speculative biotech plays like ...

Artificial intelligence is reshaping nearly every industry, but some of its biggest opportunities are emerging far from ...

Drug discovery has long been a slow, expensive process of trial and error, and for a small clinical-stage company, every wasted experiment is capital it can scarcely afford. That is the backdrop for a ...

By Kenny OlaSir: Intelligence is no more appreciated once it resides in arts and humanities. Graduates in arts and humanities are now made to appear like second class citizens in a country that once ...

One way to capitalize on the artificial intelligence (AI) industry is to invest in companies that could benefit from the ...

Blake Crouch wrote a popular science-fiction thriller novel that is just screaming for a Hollywood adaptation. So, what's the hold up?

Anthropic co-founder Jack Clark said AI agents might soon be able to build and train models themselves and, if that happens, humans could lose control over AI systems.

The word “recursion” is the latest buzzword in AI circles. Two separate startups have taken on the name, and many more have started referencing recursive self-improvement (RSI) in their roadmaps. Like ...